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Abstract 
To address the problem of underfunding of health systems in SSA the Abuja Declaration of 2001 set a target to 
allocate 15% of a country’s budget to public health expenditure. However there is no empirical evidence on 
whether SSA countries are converging or diverging from the target and whether there is significant effect of the 
Abuja instrument on other health expenditure indicators. This study tested convergence of health expenditure in 
SSA in the post Abuja declaration period. The linear dynamic panel model was estimated by GMM-IV method 
on a panel of 41 SSA countries for the period 2000 to 2011. The empirical results show evidence of absolute and 
conditional convergence of health expenditure in SSA. Real income per capita, donor funding for health care and 
benefitting from HIPC debt relief influenced direction and rate of convergence of health expenditure. The Abuja 
policy instrument (public health expenditure as a percent of government) reduced the rate of convergence of 
other health expenditure measures except for private health expenditure as percent of total health expenditure 
which was increasing in the study. The results imply that continued reliance on donor funding for health systems 
directly or through debt relief is likely to delay convergence to Abuja target. SSA governments can formulate 
sustainable health financing mechanisms that reduce dependency on external source for health system support in 
the long run. 
Keywords: Convergence, Health Expenditure, SSA, Dynamic Panel 
1. Introduction 
The Abuja declaration on increasing public health expenditure (OAU, 2001) was a landmark attempt to address 
insufficient funds allocation to the health sector in Sub-Saharan Africa (SSA). The impetus for the Abuja 
Declaration came from the challenge of persistent burden of morbidity and mortality in Africa (UN Inter- 
Agency, et al., 2012; UN DESA, 2011; World Bank, 2013). The central focus was to reduce mortality and 
morbidity arising from HIV/AIDS, Malaria and Tuberculosis (OAU, 2001). Further, the Abuja target was made 
in the context of meeting Millenium Development Goals (MDGs) on health (UN, 2000). In the Abuja 
declaration, Africa Union states committed to allocate 15% of government expenditure to the health sector. 
There also exists other global efforts to help SSA governments sustain and increase health expenditure, such as 
Global Fund (Global Fund; 2011, 2012) and President Emergency Plan for AIDS Relief (PEPFAR, 2013). 
Health expenditure in SSA before the Abuja Declaration was relatively low. For example, in the seven years 
(1995-2001) preceeding the Abuja Declaration the real per capita health expenditure, the average public health 
expenditure as a percent of total government expenditure and the average total health expenditure as a percent of 
GDP were  US$ 76.74 (2005 PPP international), 7.9%  and 5.2% respectively (World Bank, 2013). The 
corresponding world values were US$ 522, 15.1% and 9.1% respectively. 
Since the Abuja declaration health expenditure in SSA has increased and health outcomes improved (morbidity 
and mortality rates have declined). The  average  real  per capita  health expenditure  rose  by more  than  US$ 
45.10 while  the  average total health expenditure as a percent  of  GDP and  public  health expenditure as a 
percent of government expenditure increased  by about 1.3% and  1.6% respectively between 2001 and 2011 
(World Bank, 2013). Table 1, shows an upward trend in health expenditure in SSA for the period 2001- 2011 
except for private health expenditure measures. Over the same period total health expenditure as a percent of 
GDP grew by 8.4% and the Abuja policy instrument, public health expenditure as a percent of government 
expenditure increased by 12.8%. Public health expenditure as a percent of GDP increased by about 0.3% and the 
public health expenditure as a percent of total health expenditure rose by 11.5%. The increase in public health 
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expenditure measures, was accompanied by a decrease in private health expenditure measures during the post-
Abuja period. However, within the private health expenditure component the share of out of pocket expenditure 
increased by about 2.7%.Table 1 also shows that average per capita health expenditure in SSA rose by a massive 
82% over the period 2001-2011. Despite the large increase in per capita health expenditure in SSA it was one 
seventh of the World’s average per capita health expenditure. The average, however, hides large cross-country 
differences. 
However, public health spending in most SSA countries falls short of the Abuja target (Tandon and Cashin, 
2010). Consequently, the distribution and composition of health expenditure across SSA countries and overtime 
is uneven. Apart from Botswana which achieved the target for the period 2004-2007 other high per capita health 
expenditure (> US$350) SSA countries have not attained the target (World Bank, 2013).  
The  literature  on  determinants  of  health expenditure in SSA and  other  regions  is  extensive (Murthy and 
Okunade, 2009;  Temah, 2009; Ke, et al., 2011; Lu, et al., 2010). However, the issue of health expenditure 
convergence among SSA countries has not been addressed. Several studies have examined convergence of health 
expenditure in developed countries and other regions outside SSA (for example, Narayan, 2007; Wang, 2009; 
and Kerem, et al., 2008). However, SSA is unique in some respect. First, health sector in SSA countries rely 
heavily on donor funds. In 2011 donors funded more than 25% of total health expenditure in 25 SSA countries 
(World Health Organization, 2013). Second, several SSA countries received external debt relief under the HIPC 
Initiative (International Monetary Fund, 2013). Although some studies related health expenditure, donor funding 
and debt relief (Murthy and Okunade, 2009; Temah, 2009) none examined whether the two variables influenced 
convergence of health expenditure in SSA. Most countries which have achieved the Abuja target are over reliant 
on donor funding and/or benefitted from the debt relief initiatives (World Bank, 2013). 
The main aim of the study is to determine whether there is convergence of health expenditure after Abuja 
Declaration in SSA. The specific objectives are as follows; test for convergence in health expenditure in SSA 
after the Abuja Declaration; examine whether the Abuja declaration policy instrument (public health expenditure 
as a percent of government expenditure) has influenced convergence rates of other health expenditure measures 
in SSA; estimate whether donor funding, HIPC debt relief and real per capita GDP have influenced convergence 
of health expenditure in SSA. 
This study contributes to empirical literature on health expenditure in SSA in three ways. First, to the best of the 
author’s knowledge this one of the few econometric studies on health expenditure convergence in SSA. Second, 
this study considers more health expenditure measures than the studies in developed regions which have only 
tackled convergence of per capita health expenditure and total health expenditure as a percent of GDP.  
Convergence analysis of health expenditure in SSA is necessary to determine the extent of implementation of 
Abuja Declaration across its member countries. Furthermore, other initiatives aimed at the entire SSA region 
such as, Ouagadougou Declaration on primary health care and health system in Africa 2008 (Barry, et al., 2010) 
provide motivation to conduct health expenditure convergence analysis for SSA. The study of convergence of 
health expenditure allow one to understand how health systems are integrated and homogeneity in quality of 
health service delivery in SSA. The technocrats in the SSA health sector are also likely to use the study results to 
project timelines in which all member countries can achieve the Abuja target. This study is relevant in the quest 
for determining whether, member countries of SSA are converging towards the target, of allocating 15% of 
government expenditure to public health service delivery. Subsequently, it is necessary to understand how the 
increase in public health expenditure as a percent of government expenditure as influenced the upward growth of 
other health expenditure measures in SSA. When public health expenditure as share of government expenditure 
was triggered up in 2001 there was a likelihood of increase in other measures of health expenditure. This implies 
that they are likely to trend together towards a higher equilibrium. Second, the study tests for beta-convergence 
of health expenditure using dynamic panel data methods. Most of the health expenditure convergence literature 
have analyzed cross-sectional, time series data and panel data using unit root tests which yield stochastic 
convergence. Some which have attempted to measure beta convergence have used estimation methods which 
have not accounted for dynamics and endogeneity. Dynamic panel data estimation is able to account for 
endogeneity, unobserved heterogeneity and stationarity. Third, the study goes beyond estimates of both absolute 
convergence and estimates conditional convergence on health expenditure while controlling for donor funding 
and HIPC debt relief. Although, Abuja Declaration has been in force since 2001 there has been uncertainty on 
the reasons why some countries are not fully implementing it. This study has examined whether or not external 
funding of health care, real income per capita and being Heavily Indebted Poor Countries debt relief beneficiary 
have contributed to convergence of health expenditure in Sub-Saharan Africa. Knowledge of how they have 
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impacted on speed of achieving Abuja target in SSA is of high importance to deduce sources of variations in 
implementing the policy.  
The remainder of this paper is organized in four sections. Section 2, reviews the literature. Section 3, discusses 
the methodology used in the paper. Section 4 presents the empirical results on convergence of health expenditure 
measures. Section 5, presents a summary, conclusion and policy implications.  
2. Literature Review 
2.1 Convergence of Health Expenditure 
Convergence is a process in which entities become similar overtime (O’Connor, 2013). Convergence analysis of 
health expenditure borrows its theoretical model from economic growth literature (Narayan, 2007; Hitiris and 
Nixon, 2001; Hofmarcher, et al., 2004). The convergence hypothesis is in tandem with that of neoclassical 
economic growth models (Solow, 1956). The convergence hypothesis in health economics postulates that low 
healthcare spending economies tend to catch up with high health care spending ones to a common value (Hitiris, 
1997; Narayan, 2007).  
Three conceptualizations of convergence are exemplified in the literature. The beta - convergence originates 
from economic growth literature (Barro, 1984; Boyle and McCarthy, 1997). It occurs when health spending in 
low health expenditure countries increases faster than in countries with high health expenditure over a given time 
horizon (Narayan, 2007). The alternative concept of sigma -convergence in health expenditure is also borrowed 
from the economic growth literature (Baumol, 1986; Barro and Sala-i-Martin, 1992). The -convergence in 
health expenditures is experienced if cross-country variation in expenditures decline overtime (Hitiris and Nixon, 
2001). Stochastic convergence is also borrowed from economic growth literature (Benard and Durlauf, 1995; 
Carrion-i-Silvestre and German-Soto, 2008). Stochastic convergence occurs when health expenditure of one 
country relative to a reference country’s health expenditure is stationary leading to a steady state (Carrion-i-
Silvestre, 2005; Jewell, 2003).  
Another concept that has gained prominence in the convergence literature is the club convergence (Dorwick and 
Delong, 2003). In the context of health expenditure a convergence club refers to a group of countries whose 
health expenditure tends to converge to a multiple steady state e.g. the health expenditure convergence is 
conditional on income, productivity or living standards differences. Ben-David (1994) identified two forms of 
club convergence: upward convergence club consisting of countries where the members catch up with the richer 
ones. High health expenditure countries are said to be in the upward convergence club. Downward convergence 
club, comprises extremely poor countries. This form of convergence reduces disparities between high and low 
health care spending countries.  
In addition, to distinguishing -convergence, the literature distinguishes absolute (unconditional) and conditional 
convergence (Wang, 2009). Absolute -convergence, occurs when health care spending in a cross-section of 
countries converges to the same equilibrium, while conditional -convergence, occurs when health expenditure 
converges to a different equilibrium.  
 
2.2 Empirical Studies on Convergence of Health Expenditure 
The empirical literature on convergence of health expenditure has concentrated on developed regions such as 
USA, European Union and OECD (e.g. Narayan, 2007; Wang, 2009; Panopoulou and Pantelidis, 2012; Hitiris 
and Nixon, 2001; Fallahi, 2011). A variety of estimation methods and data have been used to test convergence. 
The methods include, time series, cross-sectional and panel data econometric methods. 
One strand of the literature used time series econometrics to test for convergence in health expenditure (for 
example, Narayan, 2007). For instance, the univariate and panel unit root tests such as Augmented Dickey–
Fuller (ADF) and Lagrange Multiplier (LM) with structural breaks have been used in this type of literature. 
Narayan (2007) examined whether health expenditure of Spain, Canada, Japan, Switzerland and UK converged 
to US health expenditure over the period 1960-2000. Augmented Dickey-Fuller (ADF) test and Lagrange 
multiplier (LM) univariate and panel tests with structural breaks were used. The latter complements the ADF test 
which could yield misleading results as it is insensitive to structural breaks (Perron, 1989). The ADF estimates 
showed that there was no convergence in real per capita health expenditure between USA and three countries 
(Spain, Canada and Japan) but weak convergence with that of UK. On the other hand, the LM test results of the 
study indicated that when structural breaks are taken into account there was evidence of stochastic convergence 
in per capita health expenditure of the five countries to USA per capita health expenditure. The panel LM test 
with structural breaks provided strong statistical evidence that real per capita health expenditure converged in 
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UK, Japan, Canada, Switzerland and Spain. This implies that methods with structural breaks are more relevant in 
determining stochastic convergence in health expenditure. The study concluded that per capita health 
expenditure in UK, Canada, Japan, Switzerland and Spain converged to USA’s per capita health expenditure. 
Another strand of literature on health expenditure convergence are those which have used pooled cross-section 
data (for example, Hitiris and Nixon, 2001; Kerem, 2008; Wang, 2009). Hitiris and Nixon (2001) studied the 
convergence of health expenditure (per capita health expenditure and total health expenditure as share of GDP) 
in a panel of 15 European Union (EU) countries for the period 1960-1995. The estimate of - convergence was 
based on cross-sectional data spanning 1960-1995 (with 10 years averages), while the - convergence estimate 
was based on panel data for 1980 to 1995. Non-parametric results for sigma  - convergence support 
convergence of per capita health expenditure and total health expenditure as a share of GDP. This indicated that 
variability in the health expenditure variables were falling during the period 1960 to 1995 in EU. The paper 
applied a random effect model to determine existence of - convergence. The absolute - convergence estimates 
indicated that per capita health expenditure converged at the rate of 0.11% and total health expenditure as a ratio 
of GDP converged at the rate of 0.03%.  The results also showed conditional convergence in per capita health 
expenditure at 0.09% and total health expenditure as a ratio of GDP 0.11%. The study concluded that the 
convergence estimates of health expenditure supports efforts for EU integration. 
Kerem, et al. (2008) estimated the convergence of health expenditure in the European Union using a cross-
sectional data with variables measured as averages over the period 1992 to 2004. The countries were divided in 
three groups: 23 (EU-23), 15 (EU-15) and 8 (EU-8). The authors tested for - convergence of total health 
expenditure as share of real GDP and per capita health expenditure based on Kendall’s index of rank 
concordance. The rate of convergence of total health expenditure as share of GDP ranged between 0.04% and 
0.05% among the three groups of EU member countries. The rate of convergence in per capita health 
expenditure was between 0.03% and 0.05%.  
Convergence analysis can also be carried out among states or regions within a country. For example, Wang 
(2009) examined convergence of state level per capita health expenditure in the US for the period 1980 to 2004. 
The study used cross-section regressions with bootstrap confidence interval (CI), and multivariate stationarity 
test. The paper also tested for club convergence hypothesis. The estimated rate of absolute -convergence was  -
1.7% and rate of convergence conditional on per capita income was -1.4% but statistically insignificant at 
conventional levels. Stationarity tests based on time series data revealed that 38 states formed 16 perfect 
convergence clubs consisting of two or three states. This means that stochastic convergence exists in the 
respective states. The health expenditure in 12 other states followed individual time paths. The authors 
concluded that a large number of convergence clubs is evidence of lack of convergence in health expenditure 
across US states. 
A number of studies used panel time series to test existence of health expenditure convergence (Gerdtham and 
Löthgren, 2000; Fallahi, 2011; Aslan, 2009; Lau and Fung, 2013). Gerdtham and Löthgren (2000) investigated 
stationarity (stochastic convergence) of real per capita health expenditure for 21 OECD countries for the period 
1960-1997 using ADF and Kwiatkowski-Phillips-Schimdt-Shin (KPSS) unit root tests. The ADF panel unit root 
estimates indicated that the unit root hypothesis cannot be rejected in the OECD. This may be as a result of low 
power unit-root data generation processes resulting from potential multicollinearity in the case of trending 
variables. An alternative test (KPSS) which corrects for multicollinearity with a null hypothesis of presence of 
stationarity was used in the study to verify the ADF estimates. The test rejected the presence of stationarity of 
real per capita health expenditure. This result implied that real per capita health expenditure in the 21 OECD 
countries did not converge. 
Fallahi (2011) tested for convergence of total health expenditure as a share of GDP in a panel of 10 OECD 
countries for the period 1960-2006. The test was based on LM and KPSS tests for stationarity and structural 
breaks. The beta convergence was tested using robust OLS. The panel unit root test result did not reject 
stationarity of total health expenditure as a share of GDP. This provided evidence for presence of stochastic 
convergence in total health expenditure as a share of GDP. There was no evidence of -convergence for Austria, 
Finland, Iceland, Japan and UK. But Canada, Norway and Spain converged to the US total health expenditure. 
The author concluded that real convergence (stochastic and  at the same time) existed in Canada, Ireland, 
Norway and Spain before the structural breaks. 
Aslan (2009) investigated convergence of per capita health expenditure among 19 OECD countries for the period 
1970 to 2005. The author applied both panel unit root and persistent method to determine the presence of 
convergence between USA and OECD or within OECD countries. Using panel unit root test on real per capita 
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health expenditure the unit root hypothesis was not rejected between OECD and USA and also within the OECD 
members. This indicated there was no stochastic convergence of per capita health expenditure in OECD and its 
relation with USA. Application of the persistent method1 revealed stochastic convergence of per capita health 
expenditure relative to average OECD per capita health expenditure. 
Unlike the previous studies Lau and Fung (2013) examined the existence of convergence of per capita health 
expenditure in 14 EU countries for the period 1975-2008 based on nonlinear panel unit root test. This test 
assumed that growth of health expenditure was nonlinear because of structural changes arising from regional 
integration processes in EU. The authors argued that nonlinearity had not been taken into account in most of the 
conventional unit root tests. The test used was a non-linear panel Augmented-Dickey Fuller test which accounts 
for cross-sectional dependency2. The estimates indicated that unit root hypothesis could not be rejected even 
after accounting for nonlinearity which is not different from linear panel unit root test.  
Literature on health expenditure convergence is moving toward the use of panel data estimation methods. 
Panopoulou and Pantelidis (2012) investigated whether or not per capita health expenditure in a panel of 19 
OECD countries converged over the period 1972 to 2006 and whether or not health expenditure convergence led 
to convergence in health outcomes. The paper used a methodology developed by Phillips and Sul (2007) to test 
for sigma convergence and club convergence. The estimated results show per capita health expenditure for 19 
OECD countries diverged at the rate of 0.5%.  However, the study identified two convergence clubs. One club 
comprises of Norway and USA with higher per capita health expenditure. The second convergence club 
comprises the other 17 OECD countries. They concluded that convergence lead to a rise in health expenditure 
which results in funding deficit for the health sector. However, there was no evidence that convergence in health 
expenditure was accompanied by convergence in health outcomes. 
Using a panel of 17 EU countries for the period 1990 to 2012 Apergis, et al. (2013) examined the convergence of 
various types of public expenditures as percentages of GDP. The study applied a panel convergence test 
developed by Phillips and Sul (2007) which permits testing for club convergence hypothesis. The study found 
that for the 17 countries public health expenditures did not exhibit club convergence. The study concluded that 
EU countries tend not to follow similar paths for their public health expenditure measures. 
The studies reviewed in this section lead to several conclusions regarding the existence of convergence of health 
expenditure around the world. First, hardly any studies have examined health expenditure convergence in 
developing regions and none for SSA. This study advances literature on convergence of health expenditure by 
focusing on SSA and by examining a range of health expenditure measures unlike the existing studies. In 
addition to real per capita health expenditure and  total health expenditure as a  share of GDP, public  health 
expenditure as  share of  government expenditure and,  total health expenditure and private  health expenditure as 
a  share  of  total health expenditure are examined. The conditional variables such as being a HIPC debt relief 
beneficiary and benefitting from externally (donor) funded health care are unique to SSA health system and have 
been added in the analysis to understand how they have affected the achievement of Abuja Declaration target.  
The relative effects of Abuja policy instrument (public health expenditure as a percent of government) on growth 
of other health expenditure in post Abuja period is also estimated. It applied a new approach linear dynamic 
panel model and GMM-IV estimation method to SSA data to test for the convergence. This method controls for 
endogeneity, unobserved heterogeneity and stationarity and therefore yields estimates that are more robust than 
those from standard panel data methods or time series methods. Further, the method uses dynamic instruments 
which takes care of cross-sectional dependency.  
3.  Methodology 
3.1 Theoretical Model 
The theoretical model is modified under the premise of neoclassical theory of economic convergence (Swan, 
1956; Barro, 1984; Abreu, et al., 2005). Assuming that health expenditure () is a function of real GDP per 
capita ()	 and Population (P). 
 
	
 = 		(, )   …………………………………………….…………………………………(2.1) 
                                                          
1
 Persistent method analyses unit root hypothesis by taking the ratio of per capita health expenditure for country I for period t 
to the average of the region for period t. This is then subjected to panel unit root estimation (Lima and Resende, 2007). 
2
 Cross sectional dependency refers to correlation across individual countries observations. 
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Real GDP per capita (Y) is assumed to increase health expenditure. This is because as an economy grows more 
welfare services such as provision of health care may attract more resource for improving human capital (e.g. 
health). Population is also a source of growth of health expenditure in a given country. Population influences the 
expansion of health expenditure, when additional resources are needed for health services given its health 
endowment.  
 
Equation (2.1) is a general functional form.  Assuming a Cobb-Douglas production function of health 
expenditure takes the form. 
 
	
 = ()	()…………..…………………………………………………………..…..... (2.2) 
 
The inclusion of income in the growth equation of health expenditure is motivated from Wang (2009). He noted 
that health expenditure is a vital part of consumption and it is likely to converge across regions if income 
converges. Assuming that health expenditure (ℎ) and incomes ( ) are expressed as ratio of population of a 
given country. A Taylor expansion of  ln  around the steady state  ∗ is specified as follows,  


= ( ∗ −  )…………………………………………………………….…………..… (2.3) 
 
This implies that the growth rate of income per person () is proportional to the distance between its current 
value and the steady state. " is the rate of convergence of the steady state and can be expressed as follows.  
" ≈ (1 − %)(& + ( + )). It depends on other factors such as growth of population(&), depreciation ()) and the 
growth rate of knowledge (() in a given country and other pertinent policies affecting the magnitude of health 
expenditure measure.  
Assuming that the differential equation (2.3) and using the intensive Cobb-Douglas function      ℎ = * 
equation 2.4 is derived.  
 
 +, 	(-) = (. − ,/-)  +, ∗ + ,/-  		+,(0)……………………………………............ (2.4) 
 
ℎ(0) is per capita health expenditure at time zero. Equation (2.4) is converted to a model that can be tested 
empirically. The health expenditure is measured in per capita terms, ℎ = ℎ2. Substituting for this equation in 
(2.4) it follows that, 
 
 +,	(-) −  +,(0) =	 (. − ,/-)  (0) + 3- − (. − ,/-)  +,(0) + (. −
,/-)  +, ∗	………………………………………………………………………………….. (2.5) 
 
The initial level of health expenditure growth is assumed to be constant and 4 is a vector of control variables 
such as donor funding for health, HIPC debt relief and Abuja policy instrument (public health as a percent of 
government expenditure) determines the steady state. The convergence of health expenditure model in equation 
(2.5) can be expressed as follows: 
  +,	(-) = 5 +   [+,(-)− +, (0)] + 89: ……………………….…………………... (2.6) 
 
 < 0 takes the negative sign to imply convergence. < is the vector coefficient of control variables. When the 
vector of control variables is assumed to be zero absolute convergence is determined. The  -convergence 
hypothesis states that countries with low health expenditure catch-up with those with high health expenditure 
over a given time period. 
HIPC debt relief is likely to influence the growth of health expenditure. One of the condition of the award for the 
beneficiaries was to improve health indicators by allocating the extra resources in public health services delivery. 
The Abuja policy instrument is likely explain the growth of other health expenditure measures in the health 
systems of SSA. The argument for inclusion of donor funding, HIPC debt relief and the Abuja policy instrument 
emanates from Wang (2009). He highlights the fact that coordination of policies across regions may influence 
resource redistributions which in tandem result in convergence of health expenditure where income convergence 
does not exist. 
3.2 Testing for Convergence 
This study specifies both absolute and conditional convergence of health expenditure in SSA based on the 
equation (2.6). The health expenditure variables are public health expenditure as a percent of government 
expenditure (Abuja policy instrument), real health expenditure per capita, total health expenditure as a share of 
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GDP, public health expenditure as a share of total health expenditure and private health expenditure as a share of 
total health expenditure.  
3.2.1 Absolute Convergence  
The econometric specification for absolute beta	() convergence is shown in equation (2.7). 
 
     ∆
>,- = ? + ?.
>,-/. + @>,-    i=1, 2,…, N, t=1, 2,…, (T-1)    ……………………………...(2.7)  
 
Where A,B/Cis the natural logarithm of the health expenditure variable of country i, in year           (D − 1). ∆A,B 
is the natural growth of current health expenditure from the year (D − 1) to t. EA,B is the idiosyncratic error term 
which has both time-specific and unobservable individual effects. The lagged health expenditure coefficient 
represents the convergence term. The convergence hypothesis is that high health expenditure countries tend to 
have lower health expenditure growth than low health expenditure countries. The FC  is the convergence 
coefficient of A,B/C and is expected to be negative, 	FC < 0.  
 
3.2.2 Conditional Convergence 
The econometric specification used to test for conditional beta () convergence is an extended version of 
equation (2.7). 
∆
>,- = G +G.
>,-/. + H>,-/.
9 I + J>,-    i=1, 2,…, N, t=1, 2,…, (T-1) ……………………… (2.8)  
 
Where A,B/C and   ∆A,B  are defined as in equation (2.7). KA,B/C is the vector of conditional variables. Two sets of 
conditional variables were used. One specification of the conditional variables are natural log of real income per 
capita, external funded health expenditure as percentage of total health expenditure and HIPC Debt relief dummy 
variable (to indicate whether or not a particular country was under the HIPC debt relief). In the second 
specification, the interaction of the Abuja policy instrument (public health expenditure as percent of government 
expenditure) with other health expenditure measures are added as conditional variables. This is to determine how 
change in public health expenditure as percent of government expenditure affects convergence (or divergence) of 
the other health expenditure measures. LA,B  is the idiosyncratic error term comprising time-specific and 
unobservable individual effects. 
If conditional -convergence exists the coefficient of  A,B/C expected to be negative, 	MC < 0. Under conditional 
convergence each Sub-Saharan Africa country’s health expenditure would converge to a different steady state.  
3.3 Estimation Procedure 
In this  study absolute  and conditional convergence  in health expenditure are  estimated  using  linear dynamic 
Generalized  Method  of  Moments Instrumental Variables ( LDPD GMM-IV). This hybrid estimation technique 
combines Arellano and Bond (1991), Arellano and Bover (1995) and Blundell and Bond (1998) estimators. 
Unlike static panel data methods such as fixed effects (FE) and random effects (RE), the LDPD not only controls 
for unobserved heterogeneity but also endogeneity and unit root (accounts for stationarity). The estimates of 
fixed and random effects panel data models are presented for comparison with LDPD estimates. The instrument 
used in the estimation models are classified as either GMM type or standard with them being at levels or 
differenced. GMM instruments are based on moment functions that are dependent on observable random 
variables and unknown parameters that embody zero expectation in the population when evaluation is done at 
the true parameters (Wooldridge, 2002). Standard instruments are special case of GMM which assumes there is 
no heteroscedasticity. 
The robustness for the dynamic panel estimates was checked by testing for instruments validity using Sargan 
over identification test. The Wald Criterion test was used to determine the overall significance of the estimated 
models. Finally, presence of serial correlation was tested using the Arellano-Bond autocorrelation test. 
Description of the data and variables used in the convergence regressions are displayed in Table 2.  
4. Empirical Results 
4.1 Descriptive Statistics 
The descriptive statistics for the variables considered in this chapter and defined in Table 2 are shown in Table 3. 
From Table 3, the pooled mean of total health expenditure as a ratio of GDP in the sample of countries over the 
period 2001-2011 was 5.9%. The minimum of total health expenditure as percent of GDP was reported in 
Equatorial Guinea in 2005 (1.7%) while the maximum was in Sierra Leone (22.2%) in 2009.  
The mean of Abuja declaration policy instrument (public health expenditure as a percent of government 
expenditure) was 9.5%, below the target of 15% envisaged in the declaration. This indicates that some of Sub- 
Journal of Economics and Sustainable Development                                                                                                                        www.iiste.org 
ISSN 2222-1700 (Paper) ISSN 2222-2855 (Online) 
Vol.6, No.6, 2015 
 
192 
Saharan Africa countries have not been implementing the policy. The country that reported the highest public 
health expenditure as a percent of government expenditure was Equatorial Guinea in 2002 (26.9%) while Sudan 
had the lowest 0.97% in 2001. 
The mean of public health expenditure as a percent of total health expenditure was 48.4% during 2001-2011. 
This indicates that slightly over half (51.6%) of health care expenditure in SSA was from the non-state sector. 
Congo, Democratic Republic had the lowest public health expenditure as percent of total health expenditure  at 
(5.3%)  in 2001 which culminated to having highest private  health expenditure as  a  percent of total health 
expenditure of 94.7%. On the other hand, Seychelles reported the highest public health expenditure as percent of 
total health expenditure (93.5%) in 2006 hence having the lowest private health expenditure ratio of total health 
expenditure of 6.5%. The mean of real health expenditure per capita is US$166.4. Although, higher than health 
expenditure per capita (US$ 34- US$40) recommended by Commission on Macroeconomics and Health 
(Commission on Macroeconomic and Health, 2001) the standard deviation among SSA countries is large. 
During the period 2001-2011, the minimum real health expenditure per capita (US$ 9.6) was recorded in Congo, 
Democratic Republic in 2001 while Equatorial Guinea (US$ 1,806) had the maximum real per capita health 
expenditure in 2009.  
Sub-Saharan Africa can be classified in the lower middle income category. This is because the average real GDP 
per capita (real income per capita) of US$ 3,295.80 falls within the per capita range of US$ 1035- US$4,086 as 
defined by World Bank (2014). However, the standard deviation showed large disparities in income distribution 
in the sub-continent. The lowest real GDP per capita US$247 was recorded in Congo, Democratic Republic in 
2001 while the highest (US$ 31, 968.6) was recorded in Equatorial Guinea in 2011. The average of external 
(donor) funded health expenditure, 21.8% indicated that Sub-Saharan Africa countries depend substantially on 
donor funds to run health systems. The country with the lowest donor funded health care was South Africa 
(0.2%) while Eritrea health care was highly supported by donors at 92% of their total health expenditure in 2004. 
The statistics show that during the period 2001-2011 about 30% of SSA countries benefitted from HIPC debt 
relief. . 
4.2 Absolute and Conditional Convergence of Health Expenditure in Sub-Saharan Africa 
This section presents estimates for absolute and conditional convergence of health expenditure in Sub-Saharan 
Africa corresponding to equations (2.7) and (2.8). As indicated earlier in contrast studies of developed countries 
health expenditure, this study estimated convergence of multiple measures of health expenditure. The sub-
sections 4.2.1 to 4.2.5 present econometric estimates for specific measures of health expenditure. 
4.2.1 Public Health Expenditure as a Percent of Government Expenditure  
Table 4 present estimates of absolute and conditional convergence of public health expenditure as a percent of 
government expenditure. This variable was the Abuja Declaration policy instrument picked in 2001 and the 
target was 15%. The results of two model specifications are presented. The rate of absolute convergence of 
public health expenditure as percent of government expenditure is estimated in model 1. Model 2 extends model 
3 by adding three control variables: external health expenditure as a percent of total health expenditure, HIPC 
debt relief dummy and real income per capita. This yields conditional convergence rate. As explained previously 
the GMM- IV estimator is able to control for endogeneity and autocorrelation problems. The presentation of 
results is primarily focused on GMM models. 
The p-value of the Wald test rejects the null hypothesis that the explanatory variables do not jointly explain 
growth of public health expenditure. The p-values of Sargan test for instruments validity suggest that the null 
hypothesis cannot be rejected and over identifying restrictions are valid. The Arellano Bond test of serial 
correlation does not reject the null hypothesis of no second order autocorrelation as indicated by the larger p-
values. Therefore, the diagnostic tests suggest that the estimates are consistent. 
In model 1 of Table 4, the coefficient estimate of the lagged public health expenditure as a percent of 
government expenditure is negative (-5.37) and significant (p-value = 0.03). This estimate of absolute 
convergence implies that public health expenditure as percent of government expenditure in SSA countries 
converges towards the Abuja target at the rate of 5.4% per year between 2001 and 2011. In contrast to this study 
Apergis, et al. (2013) did not find absolute convergence of health expenditure for 17 EU countries. 
Turning to conditional convergence (model 2), the coefficient estimate of lagged public health expenditure as a 
percent of government expenditure is -5.70 with p-value of 0. This indicates that the rate of conditional 
convergence  of  public  health expenditure  as a percent of  government expenditure is 5.7% conditional on 
external health expenditure as a percent of total health expenditure, being  a  beneficiary of  HIPC debt relief and  
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real income  per  capita. The percentage of health expenditure funded from external (donor) sources has positive 
but insignificant impact on growth of public health expenditure. HIPC debt relief beneficiary countries had 
higher growth in public health expenditure as a percent of government expenditure compared to non HIPC 
beneficiary countries.  Growth in real per capita income in SSA had negative impact on growth of public health 
expenditure. 
4.2.2 Real per Capita Health Expenditure  
Table 5 present the estimates of absolute convergence (model 3) and conditional convergence (Model 4 and 
Model 5) of real per capita health expenditure in SSA. In model 4 the convergence of real per capita health 
expenditure was tested conditional on whether country received debt relief under HIPC, external health 
expenditure as a percent of total health expenditure and real income per capita. Model 5, is extension of model 6. 
It includes public health expenditure as percent of government expenditure (Abuja policy instrument) and the 
interaction of public health expenditure as percentage of government expenditure and real per capita health 
expenditure. Model 5 results are  used  to determine  how  Abuja  policy instrument has  affected  the  
convergence  rate  of  real per capita  health expenditure between 2001 and 2011. 
Based on the p-values of Wald test, the null hypothesis that there is no joint significance of the explanatory 
variables is rejected. The Arellano-Bond autocorrelation test does not reject the null hypothesis of no 
autocorrelation since the test statistics are statistically insignificant as indicated by respective p-values. This 
suggests that there is no serial correlation in the first difference errors of these models. The p-value of the Sargan 
test statistic indicate that the test fails to reject the null hypothesis that the instruments used in the models are 
valid. Thus the results of diagnostic tests suggest the models are correctly specified. 
Model 3 tests for absolute convergence of real per capita health expenditure. The coefficient of the lagged real 
per capita health expenditure is -3.26 and significant at 1% level. This result suggest that SSA countries 
converged to the same equilibrium of real per capita health expenditure at the rate of 3.3% per year between 
2001 and 2011. Other studies in developed regions support the findings.  Wang (2009) found an absolute 
convergence of -1.7% in US. Hitiris and Nixon (2001) found absolute convergence of -0.03% for EU. Kerem, et 
al. (2008) also found absolute convergence ranging from -0.03% to -0.05% for per capita health expenditure in 
EU. Other studies have found stochastic convergence for per capita health expenditure (Aslan, 2009; Wang, 
2009) but Gerdtham and Löthgren (2000) and Lau and Fung (2013) did not find stochastic convergence. 
Next, focusing on model 4 to test for  conditional convergence, the coefficient of the lagged real per capita health 
expenditure is -8.74 and significant at 1%. The estimate indicate that the  convergence rate of real per capita 
health expenditure in SSA was 8.7% conditional on share of total health expenditure financed by external donor 
funding, real per capita  income and  HIPC debt relief. Thus increase in external funding for health care, real per 
capita income and having benefitted from the HIPC debt relief increased the growth of real per capita health 
expenditure. All the conditional factors had positive and significant coefficients. Hitiris and Nixon (2001) found 
conditional convergence for per capita health expenditure at -0.09% in EU and in US Wang (2009) found a 
conditional convergence of -1.4%.  
In order to test whether or not convergence rate in real per capita, health expenditure was influenced by the 
Abuja policy variable (public health expenditure as a share of total government expenditure) an interactive 
variable between one period lag of  natural log real per capita  health expenditure  and  public  health expenditure 
as  a  percentage  of  government  expenditure  was included  (Table 5, Model 5). The coefficient of lagged real 
per capita health expenditure and of the interactive variable are negative and positive respectively. Both are 
statistically significant. If SSA governments allocate 9.5% (mean) of their government budgets to public health 
the conditional convergence rate for real per capita health expenditure is about 5.5% (Table 5, Panel B). On the 
other hand, if they allocate 15% of their total government expenditure to public health the rate of conditional 
convergence is 4.55%. The coefficients of conditional variables in model 5 are positive and significant. But the 
magnitudes are smaller than in model 4. 
4.2.3 Total Health Expenditure as a Percent of GDP 
Table 6 present the results for both absolute and conditional convergence of total health expenditure as percent 
of GDP for Sub-Saharan Africa. Estimates of absolute convergence are presented under model 6. Model 7 and 
model 8 provide estimates of total health expenditure as a percent of GDP conditional convergence. 
As indicated by the p-values of the Wald test in model 6, model 7 and model 8, the null hypothesis that all 
explanatory variables coefficients are jointly zero is rejected. The Arellano-Bond autocorrelation test did not 
reject the null hypothesis of no serial correlation as indicated by the large p-values. Finally, as indicated by the p-
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values of the Sargan test, the null hypothesis that the over identification restrictions are valid cannot be rejected. 
Therefore, the instruments used in the models are valid. 
In model 6 of Table 6, the lagged total health expenditure as a percent of GDP coefficient estimate is  -5.98 and 
significant at 1%.  This indicates that total health expenditure as a percent of GDP in SSA converges towards the 
same equilibrium at the rate of 5.98% per year over the period 2001-2011. Literature from the developed region 
have also shown the same results. Kerem, et al. (2001) found absolute convergence of between -0.04% and -
0.05% for total health expenditure as a percent of GDP and Hitiris and Nixon (2001) reported a convergence of -
0.11%. Fallahi (2011) showed that total health expenditure exhibited beta convergence among some countries in 
OECD as well as stochastic convergence. 
The estimates of model 7, show that the coefficient estimate of lagged total health expenditure as a percent of 
GDP is -9.43 and significant. This means that total health expenditure as a percent of GDP conditionally 
converge at 9.43%. Hitiris and Nixon (2001) found a conditional convergence of 0.11% in EU for total health 
expenditure as a percent of GDP. The conditional variables external health expenditure as a percent of total 
health expenditure, real income per capita and being HIPC debt relief beneficiary are positive and statistically 
significant.  
Model 8 repeats the analysis but includes interaction term between total health expenditure as a percent of GDP 
and public health expenditure as a percent of government expenditure. Total health expenditure as a percent of 
GDP has a negative and significant coefficient. The coefficient of the interaction term is positive and significant. 
Panel B of Table 6, shows  that at the mean (9.5%) of  public  health expenditure as  a  percent of  government 
expenditure, the  conditional convergence  rate of  total health expenditure  as  a percent  of  GDP is 11.04%. 
However, if the public health expenditure as a percent of government expenditure is at the Abuja target (15%), 
the conditional convergence rate of total health expenditure as a percent of GDP falls to 7.56%. The results  
indicate that as  countries in SSA  implement the Abuja  declaration the  convergence  rate  of  total health 
expenditure as a percent of GDP slows across  the  member  countries. As in model 7, the conditional variables 
have positive and significant coefficients. However, the coefficients are much larger than those in model 7.  
4.2.4 Public Health Expenditure as a Percent of Total Health Expenditure  
Table 7 present  the  estimates  of  absolute  and  conditional convergence  of  public  health expenditure as a 
percent of  total health expenditure. The models pass various diagnostic tests, suggesting that they are well 
specified. The Wald test rejects the null hypothesis that all coefficient of explanatory variables are jointly equal 
to zero. Arellano-Bond autocorrelation test does not reject the null hypothesis of no serial correlation in the first 
difference errors. Sargan test does not reject the null hypothesis that over identification restrictions are valid. 
The lagged  public health expenditure as a percent of total health expenditure in model 9 is negative (-1.63) and 
significant at 1% level. The associated coefficient implies that absolute convergence of  public  health 
expenditure  as  a percent of total health expenditure  was 1.63% annually during the period 2001-2011. 
Estimates of model 10, indicate that the coefficient of public health expenditure as a percent of total health 
expenditure is -2.30 and significant at 1%. This implies that conditional on  HIPC debt relief, real income  per 
capita  and  donor  funding  for  health to public  health expenditure as a  percent  of  total health expenditure  
converged at 2.3% per year  to different steady states. The coefficient estimate of external health expenditure as 
a percent of total health expenditure (donor funding for health) is negative but insignificant. Real income per 
capita has a positive and significant coefficient while HIPC debt relief has a negative and significant coefficient. 
This means that holding other variables constant increase in real income per capita increases growth in public 
health expenditure as a percent of total health expenditure. On the other hand, holding other variables constant 
HIPC debt relief beneficiary countries had lower public health expenditure as a percent of total health 
expenditure than non HIPC debt relief countries. 
Turning to the model with interaction term (model 11), coefficient of lagged public health expenditure as a 
percent of total health expenditure is negative and significant at 1% level. The interaction term between public 
health expenditure as a percent of total health expenditure and Abuja policy instrument is positive and 
significant. When public health expenditure as a percent of government expenditure is at its mean (9.5%) the 
conditional convergence rate of public health expenditure as a percent of total health expenditure is 1.57%.  But  
when  public  health expenditure as  a  percent  of  government expenditure is  at the  Abuja target (15%) the  
conditional convergence public  health expenditure as a percent of total health expenditure is 1.2%.  Both 
external health expenditure as a percent of total health expenditure and HIPC debt relief are negative and 
significant. Real income per capita coefficient is positive and significant.  
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4.2.5 Private Health Expenditure as a Percent of Total Health Expenditure 
The estimates of absolute and conditional convergence in private health expenditure as a percent of total health 
expenditure are displayed in Table 8. All the diagnostic tests are satisfactory, suggesting the models are well 
specified. The Wald test for overall significance of explanatory variables rejects the null hypothesis of no joint 
significance. The Arellano-Bond autocorrelation test does not reject the absence of serial correlation and the 
Sargan test does not reject the over identification restrictions. 
The lagged private health expenditure as a percent of total health expenditure enters model 12 with a negative 
and significant coefficient of -1.24. This implies an absolute convergence rate of 1.24% in private health 
expenditure as a percent of total health spending. But conditional on real income per capita, HIPC debt relief and 
external health expenditure as a percent of total health expenditure (model 13) the convergence rate of private 
health expenditure as percent of total health expenditure was 0.75%. External health expenditure as a percent of 
total health expenditure (donor funding) coefficient is positive and insignificant while that one of HIPC debt 
relief enters with a positive and significant coefficient. Real income per capita enters with a negative and 
significant coefficient. An increase in real income per capita reduces the growth of private health expenditure as 
a percent of total health expenditure. The beneficiaries of HIPC debt relief had higher growth in private health 
expenditure as a percent of total health expenditure than non HIPC countries. 
The interactive term lagged share of private health expenditure in total health expenditure and share of public 
health expenditure in total government expenditure in model 14 is negative and significant. When evaluated at 
the mean (9.5%) of public health expenditure as a percent of government expenditure the conditional 
convergence rate of private health expenditure as a percent of total health expenditure was at 2.1%. But when 
evaluated at the Abuja target of 15% the conditional convergence rate increased to 2.68%.  
5.  Conclusions    
The main objective of this paper was to determine whether health expenditure in SSA has been converging since 
the Abuja declaration. Under the convergence hypothesis lower health spending countries increase their health 
expenditure allocation to catch up with their higher spending counterparts (Wang, 2009; Narayan, 2007). The 
post Abuja declaration period has been characterized by overdependence on external support as 25 SSA 
countries have over 25% of their   total health expenditure funded by donors (World Health Organization, 2013). 
Second, most of the countries which have benefitted from the HIPC debt relief are the ones who have 
implemented the Abuja target. Third, most of the high income countries in SSA have higher per capita health 
expenditure but have not reached the Abuja target 10 years on with an exception of Botswana. The aim of the 
study was to determine whether external health resources, real income per capita and HIPC debt relief affected 
convergence rates of the various health expenditure measures. It also sought to determine whether the Abuja 
target variable, public health expenditure as a percent of government expenditure, influenced the speed of 
convergence of other health expenditure measures.  
The study of convergence in social spending has been limited to developed countries even as social spending 
share of government spending in developing countries has expanded. The current study extends the literature in 
several ways. First, it examines a broader set of health expenditure measures than previous studies which only 
considered either total health expenditure as a ratio of GDP and/or per capita health expenditure. Second, the 
study provides econometric evidence on convergence of health expenditure in the developing world and Sub-
Saharan Africa using recent development in estimation of linear dynamic panel data (LDPD). Specifically, it 
applies a hybrid dynamic panel estimation technique from Arellano and Bond (1991), Arellano and Bover (1995) 
and Blundell and Bond (1998). The main advantage over other estimation methods is that it takes into account 
dynamics and controls for endogeneity, unobserved heterogeneity and stationarity.  
Third, previous studies on conditional convergence of health expenditure control only for real income per capita.  
The current study not only controls for real income per capita but also controls for two developments in SSA 
since the Abuja declaration. First, many countries became heavily reliant on external (donor) health financing. 
Second, some countries benefitted from HIPC debt relief. Fourth, the study provides evidence on the interaction 
between the Abuja policy instrument (public health expenditure as percent of government expenditure) and other 
health expenditure measures. 
The estimates of absolute convergence indicate negative and significant coefficients of lagged public  health 
expenditure as  a percent  of  government  expenditure, lagged real health expenditure  per capita, lagged total 
health expenditure as  a percent  of GDP, lagged public  health expenditure as  a percent  of  total health 
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expenditure and  lagged private health expenditure as a percent  of  total health expenditure.  Therefore, each of 
these health expenditure measures converged toward its particular steady state between 2001 and 2011. The 
estimates of the conditional convergence models indicate that taking into account important features of SSA 
relevant to health expenditure convergence of various health expenditure measures exists. In addition, 
conditional convergence rate of various health expenditure measures declined with increase in public health 
expenditure as a percent of government expenditure, with an exception of private health expenditure as a percent 
of total health expenditure. 
The estimates in the conditional models showed that external health expenditure as a percent of total health 
expenditure (donor funding) was  positive but  did not affect growth of public  health expenditure as  a  percent 
of government expenditure and private health expenditure as a share of total health expenditure during the period 
2001 to 2011.  On the other hand, it contributed to increase of real per capita health expenditure, total health 
expenditure as a share of GDP but reduced public health expenditure as a share of total health expenditure 
significantly. Real income per capita in the post Abuja declaration period 2001- 2011 reduced the growth of 
public health expenditure as a percent of government expenditure and private health expenditure as a share of 
total health expenditure significantly. But  it led to  increased  growth of real per capita  health expenditure  per  
capita, total health expenditure as  a share of GDP and public  health expenditure as  a share of  total health 
expenditure  significantly. 
Sub-Saharan Africa countries that benefitted from HIPC debt relief had a significant increased  growth in  public 
health expenditure as a percent of government expenditure, real per capita  health expenditure, total health 
expenditure as  a percent  of  GDP, private  health expenditure as  a  percent of total health expenditure more 
than the  non-beneficiaries. On the other hand, the HIPC debt relief beneficiaries had a reduced growth in public 
health expenditure as a percent of total health expenditure compared to their counterparts who did not benefit 
from the debt relief. 
In conclusion, SSA countries with low health expenditure relative to the steady state, move toward the steady 
state faster than countries whose health expenditure, is not far away from the steady state. Convergence of 
various types of health expenditure exists even after taking into account conditional factors. External health 
expenditure as a percent of total health expenditure increased the divergence of real per capita health expenditure 
and total health expenditure as a percent of GDP but led to convergence of public health expenditure as a percent 
of total health expenditure to the steady state. Real income per capita also contributed to divergence of real per 
capita health expenditure, total health expenditure as a percent of GDP and public health expenditure as a 
percent of total health expenditure. On the other hand, it lead to convergence of public health as a percent of 
government expenditure and private health expenditure as a percent of total health expenditure respectively. SSA 
countries who benefitted  from HIPC debt relief  diverged from the  steady state of public health expenditure as a 
percent of government expenditure, real per capita health expenditure, total health expenditure as a share of 
GDP, private health expenditure as  a percent of total health expenditure more than the non-HIPC countries. On 
the other hand, HIPC benefitting  countries converged to a steady state of public health expenditure as a percent 
of total health expenditure more than non HIPC ones in SSA.  
The increase in public health expenditure as a percent of government expenditure (Abuja policy instrument) 
affected the growth rate of other health expenditure measures in the period 2001-2011. The simulation at its 
mean (9.5%) shows that there was a decrease in the growth of real per capita health expenditure, total health 
expenditure as a percent of GDP, public and private health expenditure as a share of total health expenditure. 
Thus, there was increased convergence rate of the health expenditure measures. However, at the Abuja target 
(15%) the estimates showed a slower decline in the growth of health expenditure measures except for private 
health expenditure as a share of total health expenditure. This implies that as SSA countries implement the Abuja 
target other health expenditure measures variability also decrease overtime. 
Implication for the research work indicate that policy makers need to continue lobbying for its implementation 
across the Sub-Saharan Africa countries. This will motivate lower spending countries to catch up with the higher 
health spending ones in all categories of health expenditure. The presence of convergence, provide evidence that 
the total, public and private health expenditure categories are trending together in SSA. The continued upward 
convergence of  public  health expenditure (increase in growth of public health expenditure between the  period  
2001- 2011) might have  increased  health service  delivery and  quality of  life. This is through trained health 
personnel, availability of medical equipment and drugs and good infrastructure such as medical facilities. The 
downward convergence of private health expenditure (declining trends in private health expenditure in SSA in 
the period 2001-2011) indicates that they are decreasing and the burden of health care is shifting away from the 
households. This implies that vulnerability of households is decreasing. Therefore, more efforts by the policy 
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makers are needed to increase effectiveness of public health expenditure in health service delivery in order to 
cushion the vulnerable in SSA. The contribution of donor funding and HIPC debt relief to growth of some health 
expenditure measures in SSA shows over reliance on external sources to support our health systems.  
Additionally, HIPC debt relief benefitting countries showed positive growth of their health expenditure. There is 
need to introduced alternative and sustainable health financing mechanisms such as community based health 
insurance to reduce dependency on donor funding for health care and other external initiatives such as HIPC debt 
relief.  
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Table 1: Composition and Patterns of Health Expenditure in Sub-Saharan Africa 2001-2011 
 2011 Growth  in  
% (2001-
2011) 
High Health Expenditure Countries in 
2011 
Low  Health Expenditure  
Countries in 2011 
SSA 
 
World  
Total Health 
Expenditure as % of  
Gross Domestic 
Product  
6.5 10.1 8.4 Liberia (19.5%), Sierra Leone (18.8%), 
Lesotho (12.7%) 
Seychelles (3.8%), Central 
Africa, Rep. (3.8%), Eritrea 
(2.6%), Rep. of Congo 
(2.5%) 
Public  Health 
Expenditure as % of 
Gross Domestic 
Product  
3.6 5.5 0.3 Lesotho (9.5%), Liberia (6.2%), Rwanda 
(6.1%), Swaziland (5.6%) 
Guinea (1.6%), Eritrea 
(1.3%), Chad (1.2%) 
Public  Health 
Expenditure as % of 
Total Health 
Expenditure 	
45.1 59.7 11.5 Seychelles (92.1%), Cape Verde (75%), 
Equatorial Guinea (68%), Rep. of Congo 
(67%), Malawi (66%) 
Sudan (28.4%), Guinea 
(27.3%), Chad (27.1%), 
Guinea-Bissau (26.8%), 
Sierra Leone (18%) 
Public  Health 9.7 15.1 12.8 Rwanda (23.7%), Liberia (18.8%), Malawi Eritrea (3.6%), Chad (3.3%), 
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Expenditure as % of 
Government 
Expenditure 
(18.5%), Zambia (16%), Togo (15.4%), 
Madagascar (15.3%) 
Uganda (2.5%), Sudan 
(2.4%), Nigeria (2%) 
Private Health 
Expenditure as % of 
Total Health 
Expenditure	
54.9 40.3 -8.2 Sierra Leone (82%), Cote d’Ivoire (73.7%), 
Uganda (73.7%), Guinea-Bissau (73.2%), 
Guinea (72.6%), Sudan (71.6%) 
Seychelles (7.9%), Cape 
Verde (24.9%), Lesotho 
(25.9%), Malawi (26.6%) 
Out-of-Pocket Health 
Expenditure as% 
Private Health 
Expenditure 
56.5 49.7 2.7 27 countries spent >70% of total health 
expenditure. 
Only 4 spent <20%. 
Botswana, Mozambique, 
Namibia, South Africa. 
Private Health 
Expenditure as % of 
Gross Domestic 
Product	
3.6 4.1 -2.3 Sierra Leone (15.4%), Uganda (7%), Sudan 
(6%), Burundi (5.9%), DR. Congo (5.7%), 
Sao Tome and Principe (5.2%) 
Equatorial Guinea (1.3%), 
Eritrea (1.3%), Cape Verde 
(1.2%), Congo (0.8%), 
Seychelles (0.8%) 
Health Expenditure per 
Capita (US$ in PPP 
International) 
155  
1024.33 
82.1 Equatorial Guinea (1642), Seychelles 
(989.40), South Africa (942.50), Mauritius 
(841.90), Botswana (734.10),Swaziland 
(433.50), Namibia (364.80) 
Madagascar (39.60), Niger 
(39.30), DR. Congo (32.10), 
Central Africa (30.90), 
Eritrea (16.99) 
Source of data: World Bank (2013); World Health Organization (2013). 
 
Table 2: Data Sources and Definition of Variables 
Variable  Variable description Data Source 
Total health 
expenditure as % 
of GDP  
Total health expenditure is the sum of public and private health expenditure. It covers 
expenditure for the provision of health services (preventive and curative), family planning 
activities, nutrition activities, and emergency aid designated for health but does not include 
provision of water and sanitation. This is expressed as a ratio of GDP. 
World  
Development 
Indicators (World 
Bank, 2013)  
Real  health 
expenditure per 
capita  
Real health expenditure per capita is the sum of public and private health expenditures as a 
ratio of total population. Data are in international US$ converted using 2005 purchasing 
power parity (PPP) rates. 
World  
Development 
Indicators (World 
Bank, 2013) 
Public health 
expenditure as  %  
of  total health 
expenditure  
Public health expenditure consists of recurrent and capital spending from government 
(central and local) budgets, external borrowings and grants (including donations from 
international agencies and nongovernmental organizations), and social (or compulsory) 
health insurance funds. This is expressed as a ratio total health expenditure. 
World  
Development 
Indicators (World 
Bank, 2013) 
Public health 
expenditure as % 
of government 
expenditure.  
Public health expenditure consists of recurrent and capital spending expressed as ratio of 
total government expenditure. It is the Abuja Declaration 2001 policy instrument for raising 
health expenditure in Sub-Saharan Africa.   
World  
Development 
Indicators (World 
Bank, 2013) 
Private health 
expenditure as % 
of total health 
expenditure.  
Private health expenditure includes direct household (out-of-pocket) spending, private 
insurance, charitable donations, and direct service payments by private corporations. This is 
expressed as a ratio of total health expenditure. 
World  
Development 
Indicators (World 
Bank, 2013) 
External health 
expenditure as  % 
of  total health 
expenditure (donor 
funding for health 
care) 
External resources for health are funds or services in kind that are provided by entities not 
part of the country in question. The resources may come from international organizations, 
other countries through bilateral arrangements, or foreign nongovernmental organizations. 
These resources are part of total health expenditure. 
World  
Development 
Indicators (World 
Bank, 2013) 
Real income  per 
Capita  
GDP per capita based on purchasing power parity (Purchasing Power Parity).Data are in 
constant 2005 international US$. 
World  
Development 
Indicators (World 
Bank, 2013) 
HIPC  Debt relief 
Dummy variable 
Dummy variable for HIPC beneficiary countries in Sub-Saharan Africa. 1, HIPC beneficiary; 
0, otherwise. 
 Various World 
Bank Bulletins for 
HIPC beneficiary 
Countries.  
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Table 3: Descriptive Statistics of Variables included in Health Expenditure Convergence Models 
Variable Mean Std. Dev Min Max 
Total Health Expenditure as a percent  of GDP 5.9 2.6 1.7 22.2 
Public  Health Expenditure  as a  percent  of Government Expenditure 9.5 4.5 0.97 26.9 
Public  Health Expenditure as a  percent of  Total Health Expenditure 48.4 17.2 5.3 93.5 
Private Health Expenditure as a percent of Total Health Expenditure 51.6 17.2 6.5 94.7 
Real Health Expenditure  Per capita (PPP, 2005 International US$) 166.4 233.8 9.6 1806.5 
Real GDP per Capita (PPP, 2005 International US$) 3295.8 5164.9 247.9 31968.6 
External funded  health expenditure as  a percent of Total Health Expenditure 21.8 18.0 0.20 92.0 
HIPC Debt Relief Dummy (1: Beneficiary; 0 otherwise) 0.30 0.48 0 1 
Note: Number of Observations = 495. 
 
								Table 4: Absolute and Conditional Convergence of Public Health Expenditure (Dependent Variable is Growth of Public Health 
Expenditure as a Percent of Government Expenditure) 
    Notes: (1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data Model 
                (2) t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the parentheses;  
                (3) ***, **, * show significance of the estimates at 1%, 5% and 10%.  
                (4) Instruments:   Model 1 (GMM-IV four period  lagged public  health expenditure as  a percent of  government expenditure); 
Model 2 (GMM-IV two period  lagged public  health expenditure as a percent  of  government expenditure).  
 
Table 5: Absolute and Conditional Convergence of Real Health Expenditure (Dependent Variable is Growth of Real per Capita 
Health Expenditure) 
Panel A. Regression Results 
Independent Variables Model 3: Absolute  Convergence Model 4: Conditional 
Convergence I 
Model 5: Conditional 
Convergence II 
FE RE LDPD FE RE LDPD FE RE LDPD 
Independent Variables  Model 1: Absolute  Convergence Model 2: Conditional Convergence 
FE RE LDPD FE RE LDPD 
Lagged  public  health expenditure as  a percent 
of  government expenditure 
-5.316*** 
(-9.50) 
-1.623*** 
(-5.29) 
-5.369** 
(-2.19) 
-5.295*** 
(-9.30) 
-1.773*** 
(-5.33) 
-5.698*** 
(-6.70) 
Lagged  external health expenditure as a  
percent of total health expenditure 
- - - -0.02 
(-0.13) 
0.110 
(1.13) 
0.038 
(0.15) 
Lagged   ln(real GDP per capita) - - - -25.885** 
(-2.05) 
-2.075 
(-1.22) 
-54.476** 
(-2.45) 
Heavily Indebted Poor Countries (HIPC) debt 
relief dummy variable (1 if beneficiary. O 
otherwise) 
- - - 1.821 
(0.37) 
-1.754 
(-0.55) 
23.819* 
(1.70) 
Constant 55.383**
* 
(10.13) 
20.380*** 
(6.34) 
55.889**
* 
(6.18) 
247.389**
* 
(2.65) 
35.496**
* 
(2.54) 
455.047*** 
(2.33) 
Number  of Observations 450 450 450 450 450 450 
F-Test, (p-value)  90.17  
(0.00) 
- - 23.71  
(0.00) 
- - 
R-Squared 18.2 18.3 - 19.1 17.4 - 
Wald  Test  NO, (p-value) - 28.03  
(0.00) 
4.81 
(0.03) 
- 33.86 
 (0.00) 
183.09 
(p=0.00) 
Hausman test NO, (p-value) 62.16 
(0.00) 
- 64.28 
(0.00) 
- 
Sargan Test  NO, (p-value) - - 9.270 
(0.99) 
- - 12.609 
(1.00) 
Arellano-Bond Autocorrelation test (AR2)  z-
value (p=value) 
  -0.331 
(0.74) 
  -0.525 
(0.60) 
Number of Instrumental Variables  29  48 
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Lagged  ln (real health 
expenditure  per capita) 
-4.147*** 
 (-7.57) 
-
0.541**
*  
(-3.23) 
-3.259*** 
(-3.04) 
-
7.262**
* 
(-9.17) 
-
1.759**
* 
(-4.32) 
-8.736*** 
(-5.26) 
-
8.261**
* 
(-9.81) 
-
3.198*** 
(-7.64) 
-
7.220**
* 
(-3.88) 
Public  health 
expenditure as  a percent   
of  government 
expenditure* lagged ln 
(real health expenditure 
per capita) 
- - - - - - 0.155**
* 
(11.49) 
0.148*** 
(11.73) 
0.178**
* 
(3.37) 
Lagged  public  health 
expenditure as  a percent 
of  government 
expenditure 
- - - - - - -
0.453**
* 
(-6.48) 
-
0.604*** 
(-10.23) 
-
0.693**
* 
(-4.37) 
Lagged  external health 
expenditure as  percent 
of total health 
expenditure 
- - - 0.049**
* 
(2.69) 
0.002 
(0.18) 
0.117*** 
(2.82) 
0.039** 
(2.51) 
0.001 
(0.06) 
0.078** 
(2.44) 
Lagged  ln (real GDP per 
capita) 
- - - 8.409**
* 
(4.42) 
1.344**
* 
(3.11) 
12.053**
* 
(4.71) 
9.116**
* 
(4.99) 
1.490*** 
(3.50) 
8.067**
* 
(2.84) 
Heavily Indebted Poor 
Countries (HIPC) debt 
relief dummy variable 
- - - 1.095** 
(1.97) 
0.164 
(0.44) 
2.350** 
(2.27) 
0.899* 
(1.87) 
0.349 
(0.99) 
1.769**
* 
(2.87) 
Constant 20.223**
*  
(8.19) 
3.995**
* 
(5.18) 
16.227**
* 
(3.36) 
-
29.713*
** 
(-2.48) 
-0.614 
(-0.31) 
-52.095* 
(-1.81) 
-
32.580*
** 
(-2.90) 
4.063** 
(2.01) 
-
29.353*
** 
(-1.99) 
Number  of Observations 450 450 450 450 450 450 450 450 450 
F-Test,  (p-value)  57.36  
(0.00) 
- - 23.18 
(0.00) 
- - 43.76 
(0.00) 
- - 
R-Squared 0.12 0.12 - 0.19 0.17 - 0.40 0.34 - 
Wald  Test  NO, (p-value) - 10.46  
(0.00) 
17.81 
(0.00) 
- 21.35 
(0.00) 
28.56 
(0.00) 
 177.19 
(0.00) 
20.92 
(0.00) 
Hausman test NO, (p-
value) 
47.83 
(0.00) 
- 77.03 
(0.00) 
- 58.20 
(0.00) 
- 
Sargan Test  NO, (p-
value) 
- - 17.006 
(p=0.93) 
- - 53.75 
(0.13) 
 - 43.55 
(p=0.36
) 
Arellano-Bond 
Autocorrelation test 
(AR2)  z-value (p=value) 
    
-1.398 
(0.16) 
   
-1.333 
(0.18) 
   
-0.279 
(0.78) 
Number of Instrumental 
Variables 
 29 - - 48  48 
Panel B: Evaluation of the impact of Abuja policy instrument on convergence of real per capita health expenditure for conditional 
model with interactive term (model 5) (evaluated at the mean of SSA = 9.5%, Abuja Threshold =15%) 
 Mean 15% Threshold 
The coefficient estimate of lagged real per capita health expenditure. -7.220 -7.220 
The coefficient of interaction of   ln (real per  capita  health expenditure)  and public 
health expenditure as  a percent of government expenditure  (0.178)   
1.691 2.67 
Net Convergence rate -5.529 -4.55 
 
Notes:  (1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data Model 
            (2)  t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the parentheses;  
            (3) Mean value (9.5%) obtained from descriptive statistics in Table 3. 
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            (4)  Instruments: Model 3 (four period lagged ln (real per capita health expenditure) (GMM);  Model 4 (two period lagged ln (real per 
capita  health expenditure) (GMM), one  period  lagged  difference  of external health expenditure as a percent of  total health 
expenditure,  HIPC debt relief dummy);  Model 5  (two period lagged ln (real per capita health expenditure) (GMM) , one period 
lagged difference of external health expenditure as a  percent  of  total health expenditure (GMM),  one period lagged external 
health expenditure as a percent of total health expenditure and HIPC debt relief dummy ).    
 
Table 6: Absolute and Conditional Convergence of Total Health Expenditure (Dependent Variable is Growth of Total Health 
Expenditure as a Percent of GDP) 
Panel A: Regression Results 
Independent Variables Model 6: Absolute  
Convergence 
Model 7: Conditional 
Convergence I 
Model 8: Conditional 
Convergence II 
FE RE LDPD FE RE LDPD FE RE LDPD 
Lagged total health 
expenditure  as a percent of  
GDP 
-
5.558**
* 
(-9.06) 
-
0.827**
* 
(-3.00) 
-
5.979**
* 
(-4.92) 
-
6.045**
* 
(-9.42) 
-
0.863**
* 
(-3.05) 
-9.428*** 
(-3.59) 
-
11.418*
** 
(-12.98) 
-
4.969*** 
(-9.96) 
-
17.065**
* 
(-8.62) 
Public  health expenditure 
as  a percent   of  
government expenditure* 
lagged total health  
expenditure  as a percent of 
GDP 
- - - - - - 0.485**
* 
(10.62) 
0.391*** 
(10.04) 
0.634*** 
(4.23) 
Lagged  public  health 
expenditure as  a percent of  
government expenditure 
- - - - - - -
1.883**
* 
(-5.85) 
-
2.403*** 
(-9.13) 
-8.091*** 
(-8.06) 
Lagged  external health 
expenditure as a percent of 
total health expenditure 
- - - 0.121 
(1.48) 
-0.008 
(-0.16) 
0.822** 
(2.27) 
0.095 
(1.31) 
-0.040 
(-0.88) 
0.709* 
(1.83) 
Lagged  ln (real GDP per 
capita) 
- - - 11.853* 
(1.86) 
-0.645 
(-0.75) 
31.163** 
(2.12) 
11.527*
* 
(2.03) 
-0.615 
(-0.79) 
9.932* 
(1.69) 
Heavily Indebted Poor 
Countries (HIPC) debt 
relief dummy variable 
- - - 0.403 
(0.17) 
-0.239 
(-0.15) 
16.615**
* 
(2.72) 
0.736 
(0.34) 
1.711 
(0.243) 
17.004**
* 
(2.91) 
Constant 35.352*
** 
(9.70) 
7.697**
* 
(4.39) 
37.813*
** 
(5.31) 
-52.661 
(-1.13) 
12.954* 
(1.74) 
-197.478* 
(-1.73) 
-29.217 
(-0.70) 
36.361**
* 
(5.10) 
46.542 
(1.05) 
Number  of Observations 450 450 450 450 450 450 450 450 450 
F-Test, (p-value)  82.03 
(0.00) 
- - 22.39 
(0.00) 
- - 38.55 
(0.00) 
- - 
R-Squared 0.17 0.17 - 0.18 0.15 - 0.37 0.27 - 
Wald  Test  NO, (p-value)  9.00 
(0.00) 
16.77 
(0.00) 
- 9.57 
(0.05) 
13.88 
(0.01) 
 115.90 
(0.01) 
257.92 
(0.00) 
Hausman test NO, (p-value) 74.47 
(0.00) 
- 81.60 
(0.00) 
- 158.24 
(0.00) 
- 
Sargan Test  NO, (p-value) - - 44.85 
(0.12) 
- - 15.087 
(0.30) 
- - 39.38 
(0.21) 
Arellano-Bond 
Autocorrelation test (AR)  
z-value (p=value) 
 AR(2) 
-0.406 
(0.68) 
  AR(6) 
-0.983 
(0.33) 
 
 AR(2) 
0.096 
(0.92) 
Number of Instrumental 
Variables 
 37 - - 18  40 
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Panel B: Evaluation of the impact of Abuja policy instrument on convergence of total health expenditure as percent of GDP for 
conditional model (model 8) with interactive term (evaluated at the mean of SSA = 9.5%, Abuja threshold =15%) 
The coefficient estimate of lagged total health expenditure as a percent of GDP Mean Threshold (155) 
-17.065 -17.065 
The coefficient of   interaction of   total health expenditure as  a percent of GDP and public health 
expenditure as  a percent of government expenditure  (0.634)   
6.023 9.51 
Net Convergence rate -11.042 -7.555 
 
Notes: 1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data Model 
           2)  t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the parentheses;  
           3) Where p= are the probability values. 
           4) Instruments:  Model 6 (three period lagged total health expenditure as a percent of GDP (GMM): Model 7 (six period  lagged  total 
health expenditure as a  percent  of  GDP (GMM) ,  difference of   HIPC, and  one  period  lagged difference  of  external health 
expenditure as a percent  of  total health expenditure,  HIPC  debt relief dummy and  one  period   lagged  external health 
expenditure). Model 8 (two period  lagged total health expenditure as  a percent of  GDP (GMM), difference  of  growth of total 
health expenditure as  a percent of GDP, one period  lagged  difference  of  ln (real income per capita), HIPC debt relief dummy). 
 
Table 7: Absolute and Conditional Convergence of Public Health Expenditure (Dependent Variable is Growth of Public Health 
Expenditure as a Percent of Total Health Expenditure) 
Panel A: Regression Results 
Independent Variables Model 9: Absolute  
Convergence 
Model 10: Conditional 
Convergence I 
Model 11: Conditional 
Convergence II 
FE RE LDPD FE RE LDPD FE RE LDPD 
Lagged public health 
expenditure  as a percent 
of total health expenditure 
-
1.401**
* 
(-10.15) 
-
0.270**
* 
(-5.32) 
-1.633*** 
(-4.49) 
-
1.375**
* 
(-9.83) 
-
0.248**
* 
(-4.18) 
-2.302*** 
(-3.91) 
-
1.866**
* 
(-9.97) 
-
0.666**
* 
(-7.40) 
-2.203*** 
(-4.10) 
Public  health expenditure 
as  a percent   of  
government expenditure* 
lagged public health  
expenditure  as a  percent 
of total health expenditure  
-	 -	 -	 - - - 0.047**
* 
(7.02) 
0.047**
* 
(7.69) 
0.067*** 
(3.05) 
Lagged  public  health 
expenditure as  a percent 
of  government 
expenditure 
-	 -	 -	 - - - -
0.917** 
(-2.00) 
-
2.164**
* 
(-6.53) 
-0.241 
(-0.17) 
Lagged  external health 
expenditure as  a percent 
of total health expenditure 
-	 -	 -	 -0.103 
(-1.03) 
0.004 
(0.06) 
-0.210 
(-0.59) 
-0.140 
(-1.48) 
-0.055 
(-0.87) 
-0.255* 
(-1.66) 
Lagged  ln (real GDP per 
capita) 
-	 -	 -	 -3.445 
(-0.45 
-0.558 
(-0.44) 
195.930**
* 
(2.91) 
-0.241 
(-0.03) 
-0.443 
(-0.35) 
41.520*** 
(2.58) 
Heavily Indebted Poor 
Countries (HIPC) debt 
relief dummy variable 
-	 -	 -	 -0.655 
(-0.22) 
-2.685 
(-1.36) 
-25.133* 
(-1.90) 
-1.538 
(-0.55) 
-2.105 
(-1.08) 
-15.038* 
(-1.85) 
Constant 70.157*
** 
(10.47) 
15.625*
** 
(6.03) 
81.324**
* 
(4.63) 
96.963* 
(1.70) 
19.677*
* 
(2.15) 
-
1329.168*
** 
(3.15) 
83.241 
(1.54) 
37.072*
** 
(3.91) 
-219.868*** 
(-2.14) 
Number  of Observations 450 450 450 450 450 450 450 450 450 
F-Test, (p-value)  103.00 
(0.00) 
- - 26.07 
(0.00) 
- - 27.65 
(0.00) 
- - 
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R-Squared 0.20 0.20 - 0.21 0.17 - 0.29 0.21 - 
Wald  Test  NO, (p-value) - 28.34 
(0.00) 
20.12 
(0.00) 
- 29.93 
(0.00) 
18.51 
(0.00) 
 96.26 
(0.00) 
134.01 
(0.00) 
Hausman test NO , (p-
value) 
77.63 
(0.00) 
- 82.50 
(0.00) 
 117.58 
(0.00) 
- 
Sargan Test  NO, (p-value) -	 - 27.879 
(0.97) 
-	 -	 18.889 
(0.76)	
-	 - 21.738 
(0.99) 
Arellano-Bond 
Autocorrelation test (AR)  
z-value (p=value) 
	   
1.235 
(0.22) 
	 	  
1.221 
(0.22)	
	   
-0.501 
(0.62) 
Number of Instrumental 
Variables 
 46 - - 29  48 
Panel B: Evaluation of the impact of Abuja policy instrument on convergence of public health expenditure as percent of total health 
expenditure for conditional model with interactive term (model 11) (evaluated at the mean of SSA = 9.5%, Abuja threshold =15%) 
The coefficient estimate of lagged public  health expenditure as a  percent  of total health expenditure Mean Threshold  
-2.203 -2.203 
The  interaction of  public  health expenditure as  a percent  of total health expenditure with public health 
expenditure as a percent of government expenditure  (0.067)   
0.637 1.005 
Net Convergence rate -1.566 -1.198 
 
Notes:1)  FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data Model. 
          2) t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the parentheses.  
          3) Where p= are the probability values. 
         4) Instruments: Model 9 (two period lags of public health expenditure as a percent of total health expenditure (GMM): Model 10 (three 
period lags of growth of public health expenditure as  a percent of total health expenditure (GMM)): Model 11 (two period  lags  
of public health expenditure as  a percent  of  total health expenditure (GMM), one  period  lagged difference  of external health 
expenditure as a  (GMM), one  period  lagged  difference  of  public  health expenditure as  a percent  of total health expenditure 
(GMM) and one  period lag of  public health expenditure as  percent  of total health expenditure).  
 
Table 8: Absolute and Conditional Convergence of Private Health Expenditure (Dependent Variable is the Growth of Private Health 
Expenditure as a Percent of Total Health Expenditure) 
Panel A: Regression Analysis 
Independent Variables Model 12: Absolute  
Convergence 
Model 13: Conditional 
Convergence I 
Model 14: Conditional 
Convergence II 
FE RE LDPD FE RE LDPD FE RE LDPD 
Lagged private health 
expenditure  as a percent of 
total health expenditure 
-
0.949**
* 
(-10.33) 
-
0.106**
* 
(-3.21) 
-
1.241* 
(-1.79) 
-
0.959**
* 
(-10.31) 
-
0.126**
* 
(-3.20) 
-
0.753** 
(-2.20) 
-
0.507**
* 
(-4.79) 
0.343**
* 
(6.82) 
-1.015** 
(-2.43) 
Public  health expenditure as  
a percent   of  government 
expenditure* lagged private 
health  expenditure  as a 
percent of total health 
expenditure  
- - - - - - - 
0.059**
* 
(-13.68) 
-
0.047**
* 
(-12.84) 
-0.105*** 
(-6.68) 
Lagged  public  health 
expenditure as  a percent of  
government expenditure 
- - - - - - 1.287**
* 
(4.87) 
2.538**
* 
(11.82) 
-0.074 
(-0.05) 
Lagged  external health 
expenditure as a percent of 
total health expenditure 
- - - -0.048 
(-0.73) 
-0.033 
(-0.77) 
0.135 
(0.77) 
-0.010 
(-0.19) 
-0.054 
(-1.49) 
-0.013 
(-0.14) 
Lagged  log  of  real GDP per 
capita 
- - - 5.413 
(1.06) 
-0.786 
(-0.94) 
-
22.504*
1.605 
(0.38) 
-0.540 
(-0.75) 
-
54.144**
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* 
(-2.13) 
* 
(-3.69) 
Heavily Indebted Poor 
Countries (HIPC) debt relief 
dummy variable 
- - - -1.575 
(-0.80) 
-0.481 
(-0.37) 
9.236* 
(1.97) 
-1.218 
(-0.03) 
0.296 
(0.26) 
16.932** 
(2.44) 
Constant 48.848*
** 
(10.20) 
5.169**
* 
(2.87) 
63.979
* 
(1.78) 
10.775 
(0.28) 
12.576 
(1.53) 
199.667
** 
(2.24) 
29.820 
(0.92) 
-
15.026* 
(-1.92) 
498.233*
** 
(3.54) 
Number  of Observations 450 450 450 450 450 450 450 450 405 
F-Test, (p-value)  106.70 
(0.00) 
- - 27.09 
(0.00) 
- - 57.77 
(0.00) 
- - 
R-Squared 0.21 0.21 - 0.21 0.18 - 0.47 0.35 - 
Wald  Test  NO, (p-value) - 10.33 
(0.00) 
3.22 
(0.07) 
- 11.57 
(0.02) 
94.67 
(0.00) 
- 189.82 
(0.00) 
335.92 
(0.00) 
Hausman test NO, (p-value) 96.65 
(0.00) 
- 99.64 
(0.00) 
- 82.11 
(0.00) 
- 
Sargan Test  NO, (p-value) - - 7.802 
(0.90) 
  35.378 
(0.36) 
- - 21.546 
(0.25) 
Arellano-Bond 
Autocorrelation test (AR)  z-
value (p=value) 
 AR(6) 
-0.942 
(0.35) 
  AR(3) 
-0.249 
(0.80) 
 AR(5) 
0.048 
(0.96) 
Number of Instrumental 
Variables 
 16   38  25 
Panel B: Evaluation of the impact of Abuja policy instrument on convergence of private health expenditure as percent of total health 
expenditure for conditional model with interactive term (model 14) (evaluated at the mean of SSA = 9.5%, Abuja threshold =15%) 
The coefficient estimate of lagged private health expenditure as  a percent  of total health expenditure Mean Threshold  
-1.105 -1.105 
The coefficient of  interaction of  private  health expenditure as  percent  of total health expenditure and 
public health expenditure as a percent of government expenditure  (0.067)   
-0.998 -1.575 
Net Convergence rate -2.103 -2.68 
 
Notes: 1)  FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data Model. 
            2)  t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the parentheses; 
            3) Where p= are the probability values. 
            4) The instruments: Model 12 (  six period lags of private health expenditure as a percent of total health expenditure (GMM)): Model 
13 (three period lags of external health expenditure as a percent of  total health expenditure (GMM), one  period lagged difference   
of  private  health expenditure as  percent  of  total health expenditure (GMM)  and one  period lag of  private health expenditure 
as  percent  of  total health expenditure): Model 14 ( five  period  lagged private  health expenditure (GMM), one  period  lagged  
difference  of  external health expenditure as  a  percent  of  total health expenditure, one  period  lagged  difference  of  private  
health expenditure as  a  percent of  total health expenditure, difference of  public  health expenditure as  a percent of  government 
expenditure, one  period  lagged  private  health expenditure as  a  percent of  total health expenditure).  
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